AI is stepping in to help speed up the diagnosis of COVID-19 and expedite how much time healthcare professionals spend determining COVID-19 pneumonia and non-COVID-19 cases.
What the five have in common are software products aimed at helping providers improve patient engagement by leveraging AI. The recognized companies also meet IDC’s criteria for having revenues below $100 million.
U.S. Army researchers are calling for the creation of a national emergency network that would coordinate select digital health technologies, including AI, in fighting COVID-19 now and other public health crises later.
Healthcare AI companies of all sizes need patient data to design their products and make their fortunes. Big healthcare providers have the data and need the tech partners to help advance modern medicine.
Johns Hopkins radiologists have repurposed a deep learning algorithm designed to detect tuberculosis on chest x-rays to, instead, help identify COVID-19.
The European Union has certified AI software for reading mammograms, clearing the way for a South Korea-based AI vendor to sell another of its AI products across the European Economic Area.
A vendor that supplies EHR software to public health agencies is partnering with a health-tech startup in the cloud-communications space to equip state and local governments for managing their response to the COVID-19 crisis.